159 related articles for article (PubMed ID: 20119713)
1. Epigenetic silencing of WIF-1 in hepatocellular carcinomas.
Deng Y; Yu B; Cheng Q; Jin J; You H; Ke R; Tang N; Shen Q; Shu H; Yao G; Zhang Z; Qin W
J Cancer Res Clin Oncol; 2010 Aug; 136(8):1161-7. PubMed ID: 20119713
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of Wnt inhibitory factor-1 expression in hepatocellular carcinoma that is independent of gene methylation.
Huang L; Li MX; Wang L; Li BK; Chen GH; He LR; Xu L; Yuan YF
Tumour Biol; 2011 Feb; 32(1):233-40. PubMed ID: 21052890
[TBL] [Abstract][Full Text] [Related]
3. Promoter methylation and mRNA expression of DKK-3 and WIF-1 in hepatocellular carcinoma.
Ding Z; Qian YB; Zhu LX; Xiong QR
World J Gastroenterol; 2009 Jun; 15(21):2595-601. PubMed ID: 19496188
[TBL] [Abstract][Full Text] [Related]
4. Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers.
Taniguchi H; Yamamoto H; Hirata T; Miyamoto N; Oki M; Nosho K; Adachi Y; Endo T; Imai K; Shinomura Y
Oncogene; 2005 Nov; 24(53):7946-52. PubMed ID: 16007117
[TBL] [Abstract][Full Text] [Related]
5. Loss of WIF-1 and Wnt5a expression is related to aggressiveness of sporadic breast cancer in Tunisian patients.
Trifa F; Karray-Chouayekh S; Jmal E; Jmaa ZB; Khabir A; Sellami-Boudawara T; Frikha M; Daoud J; Mokdad-Gargouri R
Tumour Biol; 2013 Jun; 34(3):1625-33. PubMed ID: 23417837
[TBL] [Abstract][Full Text] [Related]
6. Functional significance of Wnt inhibitory factor-1 gene in kidney cancer.
Kawakami K; Hirata H; Yamamura S; Kikuno N; Saini S; Majid S; Tanaka Y; Kawamoto K; Enokida H; Nakagawa M; Dahiya R
Cancer Res; 2009 Nov; 69(22):8603-10. PubMed ID: 19887605
[TBL] [Abstract][Full Text] [Related]
7. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
Li Z; Zhang H; Yang J; Hao T; Li S
Cell Biol Int; 2012 May; 36(5):427-32. PubMed ID: 21864295
[TBL] [Abstract][Full Text] [Related]
8. Promoter demethylation of WIF-1 by epigallocatechin-3-gallate in lung cancer cells.
Gao Z; Xu Z; Hung MS; Lin YC; Wang T; Gong M; Zhi X; Jablon DM; You L
Anticancer Res; 2009 Jun; 29(6):2025-30. PubMed ID: 19528461
[TBL] [Abstract][Full Text] [Related]
9. Wnt inhibitory factor-1 is silenced by promoter hypermethylation in human lung cancer.
Mazieres J; He B; You L; Xu Z; Lee AY; Mikami I; Reguart N; Rosell R; McCormick F; Jablons DM
Cancer Res; 2004 Jul; 64(14):4717-20. PubMed ID: 15256437
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional regulation of Wnt inhibitory factor-1 by Miz-1/c-Myc.
Licchesi JD; Van Neste L; Tiwari VK; Cope L; Lin X; Baylin SB; Herman JG
Oncogene; 2010 Nov; 29(44):5923-34. PubMed ID: 20697356
[TBL] [Abstract][Full Text] [Related]
11. Integrator complex subunit 6 (INTS6) inhibits hepatocellular carcinoma growth by Wnt pathway and serve as a prognostic marker.
Lui KY; Zhao H; Qiu C; Li C; Zhang Z; Peng H; Fu R; Chen HA; Lu MQ
BMC Cancer; 2017 Sep; 17(1):644. PubMed ID: 28899352
[TBL] [Abstract][Full Text] [Related]
12. Frequent concomitant epigenetic silencing of SOX1 and secreted frizzled-related proteins (SFRPs) in human hepatocellular carcinoma.
Shih YL; Hsieh CB; Yan MD; Tsao CM; Hsieh TY; Liu CH; Lin YW
J Gastroenterol Hepatol; 2013 Mar; 28(3):551-9. PubMed ID: 23215838
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic inactivation of the canonical Wnt antagonist secreted frizzled-related protein 1 in hepatocellular carcinoma cells.
Wu Y; Li J; Sun CY; Zhou Y; Zhao YF; Zhang SJ
Neoplasma; 2012; 59(3):326-32. PubMed ID: 22296502
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.
Lim SO; Gu JM; Kim MS; Kim HS; Park YN; Park CK; Cho JW; Park YM; Jung G
Gastroenterology; 2008 Dec; 135(6):2128-40, 2140.e1-8. PubMed ID: 18801366
[TBL] [Abstract][Full Text] [Related]
15. Hypermethylation of growth arrest DNA damage-inducible gene 45 beta promoter in human hepatocellular carcinoma.
Qiu W; Zhou B; Zou H; Liu X; Chu PG; Lopez R; Shih J; Chung C; Yen Y
Am J Pathol; 2004 Nov; 165(5):1689-99. PubMed ID: 15509538
[TBL] [Abstract][Full Text] [Related]
16. The silencing of RECK gene is associated with promoter hypermethylation and poor survival in hepatocellular carcinoma.
Zhang C; Ling Y; Zhang C; Xu Y; Gao L; Li R; Zhu J; Fan L; Wei L
Int J Biol Sci; 2012; 8(4):451-8. PubMed ID: 22419890
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of WIF-1 by hypermethylation in astrocytomas.
Yang Z; Wang Y; Fang J; Chen F; Liu J; Wu J; Wang Y; Song T; Zeng F; Rao Y
Acta Biochim Biophys Sin (Shanghai); 2010 Jun; 42(6):418-25. PubMed ID: 20539942
[TBL] [Abstract][Full Text] [Related]
18. Aberrant promoter methylation of WIF-1 and SFRP1, 2, 4 genes in mesothelioma.
Kohno H; Amatya VJ; Takeshima Y; Kushitani K; Hattori N; Kohno N; Inai K
Oncol Rep; 2010 Aug; 24(2):423-31. PubMed ID: 20596629
[TBL] [Abstract][Full Text] [Related]
19. Wnt signaling activation and WIF-1 silencing in nasopharyngeal cancer cell lines.
Lin YC; You L; Xu Z; He B; Mikami I; Thung E; Chou J; Kuchenbecker K; Kim J; Raz D; Yang CT; Chen JK; Jablons DM
Biochem Biophys Res Commun; 2006 Mar; 341(2):635-40. PubMed ID: 16427602
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic inactivation of Wnt inhibitory factor-1 in human esophageal squamous cell carcinoma.
Yang SH; Li SL; Dong ZM; Kan QC
Oncol Res; 2012; 20(2-3):123-30. PubMed ID: 23193918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
